BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 23888359)

  • 1. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.
    Dadds MR; MacDonald E; Cauchi A; Williams K; Levy F; Brennan J
    J Autism Dev Disord; 2014 Mar; 44(3):521-31. PubMed ID: 23888359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
    Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
    Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
    Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
    Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
    Guastella AJ; Einfeld SL; Gray KM; Rinehart NJ; Tonge BJ; Lambert TJ; Hickie IB
    Biol Psychiatry; 2010 Apr; 67(7):692-4. PubMed ID: 19897177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
    Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
    Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
    Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
    J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
    Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
    Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
    Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
    Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
    Sikich L; Kolevzon A; King BH; McDougle CJ; Sanders KB; Kim SJ; Spanos M; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Witters Cundiff A; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Siecinski SK; Giamberardino SN; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; Gregory SG; Veenstra-VanderWeele J
    N Engl J Med; 2021 Oct; 385(16):1462-1473. PubMed ID: 34644471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
    Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
    Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism.
    Auyeung B; Lombardo MV; Heinrichs M; Chakrabarti B; Sule A; Deakin JB; Bethlehem RA; Dickens L; Mooney N; Sipple JA; Thiemann P; Baron-Cohen S
    Transl Psychiatry; 2015 Feb; 5(2):e507. PubMed ID: 25668435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial.
    Le J; Zhang L; Zhao W; Zhu S; Lan C; Kou J; Zhang Q; Zhang Y; Li Q; Chen Z; Fu M; Montag C; Zhang R; Yang W; Becker B; Kendrick KM
    Psychother Psychosom; 2022; 91(5):335-347. PubMed ID: 35545057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
    Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders.
    Hollander E; Novotny S; Hanratty M; Yaffe R; DeCaria CM; Aronowitz BR; Mosovich S
    Neuropsychopharmacology; 2003 Jan; 28(1):193-8. PubMed ID: 12496956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
    Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
    Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial.
    Aoki Y; Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Takao H; Kawakubo Y; Kasai K; Yamasue H
    Mol Psychiatry; 2015 Apr; 20(4):447-53. PubMed ID: 25070538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
    Yamasue H; Okada T; Munesue T; Kuroda M; Fujioka T; Uno Y; Matsumoto K; Kuwabara H; Mori D; Okamoto Y; Yoshimura Y; Kawakubo Y; Arioka Y; Kojima M; Yuhi T; Owada K; Yassin W; Kushima I; Benner S; Ogawa N; Eriguchi Y; Kawano N; Uemura Y; Yamamoto M; Kano Y; Kasai K; Higashida H; Ozaki N; Kosaka H
    Mol Psychiatry; 2020 Aug; 25(8):1849-1858. PubMed ID: 29955161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial.
    Moerkerke M; Daniels N; Van der Donck S; Tibermont L; Tang T; Debbaut E; Bamps A; Prinsen J; Steyaert J; Alaerts K; Boets B
    J Child Psychol Psychiatry; 2023 Nov; 64(11):1583-1595. PubMed ID: 37278339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.
    Aoki Y; Yahata N; Watanabe T; Takano Y; Kawakubo Y; Kuwabara H; Iwashiro N; Natsubori T; Inoue H; Suga M; Takao H; Sasaki H; Gonoi W; Kunimatsu A; Kasai K; Yamasue H
    Brain; 2014 Nov; 137(Pt 11):3073-86. PubMed ID: 25149412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial.
    Kruppa JA; Gossen A; Oberwelland Weiß E; Kohls G; Großheinrich N; Cholemkery H; Freitag CM; Karges W; Wölfle E; Sinzig J; Fink GR; Herpertz-Dahlmann B; Konrad K; Schulte-Rüther M
    Neuropsychopharmacology; 2019 Mar; 44(4):749-756. PubMed ID: 30390065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.